Gateway 2012: Brabender Pharma
Brabender® Pharma USA, Inc.
50 East Wesley Street
South Hackensack, NJ 07606
Kevin Van Allen
201.220.6660
cwbi@cwbrabender.comwww.brabender-pharma.com
Be sure to visit us at AAPS 2012, booth # 4900
Brabender® Pharma USA, Inc. is an innovative company specializing in the manufacturing of twin-screw extruders for HME applications. The effort has been to concentrate on top quality equipment to produce small batch sizes up to production scale processes. The 12 mm Mini-Compounder is ideally suited to this undertaking while other models offer options to achieve production capacity. Our success is accomplished by many years of knowledge in this area – we present a solution to the increased demand for small batch analysis while providing the finest quality equipment and instruments. Brabender® Pharma is pleased to announce the opening of our new GMP Pharma Testing Laboratory located in Duisburg, Germany. With the introduction of this laboratory, we complement our customers’ needs for a GMP testing laboratory utilizing our 12 mm Mini-Compounder for HME – Hot Melt Extrusion.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
